Belimumab for the Treatment of Early Diffuse Systemic Sclerosis-Reference-Cited by-同舟云学术

Belimumab for the Treatment of Early Diffuse Systemic Sclerosis

Published:2017-12-29 Issue:2 Volume:70 Page:308-316
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

Gordon Jessica K.¹^ORCID,Martyanov Viktor²,Franks Jennifer M.²,Bernstein Elana J.³,Szymonifka Jackie³,Magro Cynthia⁴,Wildman Horatio F.⁴,Wood Tammara A.²,Whitfield Michael L.²,Spiera Robert F.¹

Affiliation:

1. Hospital for Special Surgery New York New York

2. Geisel School of Medicine at Dartmouth Hanover New Hampshire

3. New York Presbyterian Hospital Columbia University New York New York

4. Weill Cornell Medical College New York New York

Funder

GlaxoSmithKline

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.40358

Reference43 articles.

1. Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being

2. Pathogenesis of Systemic Sclerosis

3. Old medications and new targeted therapies in systemic sclerosis

4. Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)

5. B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disruption of memory B-cell trafficking by belimumab in patients with systemic lupus erythematosus;Rheumatology;2024-05-22

2. Interstitial Lung Disease Associated with Systemic Sclerosis;Seminars in Respiratory and Critical Care Medicine;2024-05-07

3. Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies;Antibodies;2024-02-01

4. Immune-Targeted Therapies in SSc;Scleroderma;2024

5. Progress in Clinical Research on Belimumab in the Treatment of Rheumatic Diseases;Advances in Clinical Medicine;2024